Journey Medical Corporation DERM Business Segments — Net Income Loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's business segments — net income loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Journey Medical Corporation's business segments — net income loss?
- Journey Medical Corporation (DERM) reported business segments — net income loss of -$2.23M in Q1 2026.
- How has Journey Medical Corporation's business segments — net income loss changed year-over-year?
- Journey Medical Corporation's business segments — net income loss increased by 45.2% year-over-year, from -$4.07M to -$2.23M.
- What does business segments — net income loss mean?
- This metric represents the final profitability of the dermatological segment after deducting all associated costs and expenses from the segment's total revenue. It indicates the segment's ability to generate value independently and its contribution to the overall financial health of the parent corporation. A positive trend in this metric demonstrates successful commercial execution and effective cost management within the dermatology business.